FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2004018032> ?p ?o ?g. }

• W2004018032 endingPage "972" @default.
• W2004018032 startingPage "964" @default.
• W2004018032 abstract "Telmisartan is a unique angiotensin II (Ang II) receptor blocker (ARB) with selective peroxisome proliferator-activated receptor-gamma (PPAR gamma). We therefore investigated the effects of telmisartan on endothelial function and atherosclerotic change in genetically hyperlipidemic rabbits, compared with candesartan, an ARB without PPAR gamma activity.A total of 30 Watanabe heritable hyperlipidemic (WHHL) rabbits equally derived (n = 6 each) were treated with (1) vehicle (control), (2) GW9662, a PPAR gamma antagonist (0.5 mg/kg per day), (3) telmisartan (5 mg/kg per day), (4) telmisartan + GW9662, (5) candesartan (5 mg/kg per day) for 8 weeks. After treatment, acetylcholine (ACh)-induced nitric oxide production was measured as a surrogate for endothelium protective function, and vascular nitrotyrosine (a product of superoxide and nitric oxide) was measured for assessing dysfunctional endothelial nitric oxide synthase activity. Plaque area was quantified by histology.Telmisartan increased ACh-induced nitric oxide by 5.5 nmol/l, significantly more than control. Interestingly, cotreatment with GW9662 significantly attenuated telmisartan-induced ACh-induced nitric oxide almost to the levels observed with candesartan. Vascular nitrotyrosine concentration was 1.4 pmol/mg protein in the control group and significantly higher than that in the telmisartan or candesartan group. The lowest nitrotyrosine concentration was observed in the telmisartan group, which was significantly lower than that in the candesartan or telmisartan + GW9662 group. Histology of the thoracic aorta revealed that the plaque area was more significantly decreased in the telmisartan group than in the candesartan or telmisartan + GW9662 group.In addition to a class effect of ARBs, telmisartan may have additional effects on nitric oxide bioavailability and atherosclerotic change through its PPAR gamma-mediated effects in genetically hyperlipidemic rabbits." @default.
• W2004018032 created "2016-06-24" @default.
• W2004018032 creator A5000322274 @default.
• W2004018032 creator A5018979358 @default.
• W2004018032 creator A5025333302 @default.
• W2004018032 creator A5029137998 @default.
• W2004018032 creator A5034582612 @default.
• W2004018032 creator A5045305420 @default.
• W2004018032 creator A5059019226 @default.
• W2004018032 creator A5059425294 @default.
• W2004018032 creator A5075639265 @default.
• W2004018032 creator A5077761521 @default.
• W2004018032 creator A5088861691 @default.
• W2004018032 date "2008-05-01" @default.
• W2004018032 modified "2023-10-01" @default.
• W2004018032 title "Effects of telmisartan, a unique angiotensin receptor blocker with selective peroxisome proliferator-activated receptor-γ-modulating activity, on nitric oxide bioavailability and atherosclerotic change" @default.
• W2004018032 cites W1576835394 @default.
• W2004018032 cites W1974906595 @default.
• W2004018032 cites W1978245407 @default.
• W2004018032 cites W1981018813 @default.
• W2004018032 cites W1982581996 @default.
• W2004018032 cites W1988531324 @default.
• W2004018032 cites W1993952575 @default.
• W2004018032 cites W1999649376 @default.
• W2004018032 cites W2008047670 @default.
• W2004018032 cites W2008048680 @default.
• W2004018032 cites W2019249650 @default.
• W2004018032 cites W2025553759 @default.
• W2004018032 cites W2048748448 @default.
• W2004018032 cites W2050548878 @default.
• W2004018032 cites W2065133286 @default.
• W2004018032 cites W2072477280 @default.
• W2004018032 cites W2080138126 @default.
• W2004018032 cites W2089592415 @default.
• W2004018032 cites W2117854326 @default.
• W2004018032 cites W2124166947 @default.
• W2004018032 cites W2129380039 @default.
• W2004018032 cites W2129697991 @default.
• W2004018032 cites W2159083249 @default.
• W2004018032 cites W2159316372 @default.
• W2004018032 cites W2159424655 @default.
• W2004018032 cites W4247794967 @default.
• W2004018032 doi "https://doi.org/10.1097/hjh.0b013e3282f52c36" @default.
• W2004018032 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/18398339" @default.
• W2004018032 hasPublicationYear "2008" @default.
• W2004018032 type Work @default.
• W2004018032 sameAs 2004018032 @default.
• W2004018032 citedByCount "38" @default.
• W2004018032 countsByYear W20040180322012 @default.
• W2004018032 countsByYear W20040180322013 @default.
• W2004018032 countsByYear W20040180322014 @default.
• W2004018032 countsByYear W20040180322016 @default.
• W2004018032 countsByYear W20040180322017 @default.
• W2004018032 countsByYear W20040180322018 @default.
• W2004018032 countsByYear W20040180322019 @default.
• W2004018032 countsByYear W20040180322020 @default.
• W2004018032 countsByYear W20040180322023 @default.
• W2004018032 crossrefType "journal-article" @default.
• W2004018032 hasAuthorship W2004018032A5000322274 @default.
• W2004018032 hasAuthorship W2004018032A5018979358 @default.
• W2004018032 hasAuthorship W2004018032A5025333302 @default.
• W2004018032 hasAuthorship W2004018032A5029137998 @default.
• W2004018032 hasAuthorship W2004018032A5034582612 @default.
• W2004018032 hasAuthorship W2004018032A5045305420 @default.
• W2004018032 hasAuthorship W2004018032A5059019226 @default.
• W2004018032 hasAuthorship W2004018032A5059425294 @default.
• W2004018032 hasAuthorship W2004018032A5075639265 @default.
• W2004018032 hasAuthorship W2004018032A5077761521 @default.
• W2004018032 hasAuthorship W2004018032A5088861691 @default.
• W2004018032 hasConcept C104849204 @default.
• W2004018032 hasConcept C126322002 @default.
• W2004018032 hasConcept C134018914 @default.
• W2004018032 hasConcept C170493617 @default.
• W2004018032 hasConcept C187345961 @default.
• W2004018032 hasConcept C2777622882 @default.
• W2004018032 hasConcept C2779716603 @default.
• W2004018032 hasConcept C2780036600 @default.
• W2004018032 hasConcept C2908929049 @default.
• W2004018032 hasConcept C519581460 @default.
• W2004018032 hasConcept C71924100 @default.
• W2004018032 hasConcept C84393581 @default.
• W2004018032 hasConcept C98274493 @default.
• W2004018032 hasConceptScore W2004018032C104849204 @default.
• W2004018032 hasConceptScore W2004018032C126322002 @default.
• W2004018032 hasConceptScore W2004018032C134018914 @default.
• W2004018032 hasConceptScore W2004018032C170493617 @default.
• W2004018032 hasConceptScore W2004018032C187345961 @default.
• W2004018032 hasConceptScore W2004018032C2777622882 @default.
• W2004018032 hasConceptScore W2004018032C2779716603 @default.
• W2004018032 hasConceptScore W2004018032C2780036600 @default.
• W2004018032 hasConceptScore W2004018032C2908929049 @default.
• W2004018032 hasConceptScore W2004018032C519581460 @default.
• W2004018032 hasConceptScore W2004018032C71924100 @default.
• W2004018032 hasConceptScore W2004018032C84393581 @default.
• W2004018032 hasConceptScore W2004018032C98274493 @default.
• W2004018032 hasIssue "5" @default.
• W2004018032 hasLocation W20040180321 @default.
• W2004018032 hasLocation W20040180322 @default.

• next